These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9839000)
1. Synthesis and in vitro activity of some epimeric 20 alpha-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17 alpha-hydroxylase/C17,20-lyase and 5 alpha-reductase. Ling YZ; Li JS; Kato K; Liu Y; Wang X; Klus GT; Marat K; Nnane IP; Brodie AM Bioorg Med Chem; 1998 Oct; 6(10):1683-93. PubMed ID: 9839000 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2. Hartmann RW; Hector M; Haidar S; Ehmer PB; Reichert W; Jose J J Med Chem; 2000 Nov; 43(22):4266-77. PubMed ID: 11063622 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17). Hartmann RW; Hector M; Wachall BG; Palusczak A; Palzer M; Huch V; Veith M J Med Chem; 2000 Nov; 43(23):4437-45. PubMed ID: 11087568 [TBL] [Abstract][Full Text] [Related]
4. 20-amino and 20,21-aziridinyl pregnene steroids: development of potent inhibitors of 17 alpha-hydroxylase/C17,20-lyase (P450 17). Njar VC; Hector M; Hartmann RW Bioorg Med Chem; 1996 Sep; 4(9):1447-53. PubMed ID: 8894102 [TBL] [Abstract][Full Text] [Related]
5. 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha). Ling YZ; Li JS; Liu Y; Kato K; Klus GT; Brodie A J Med Chem; 1997 Sep; 40(20):3297-304. PubMed ID: 9379450 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of androgen synthesis by 22-hydroximino-23,24-bisnor-4-cholen-3-one. Li J; Li Y; Son C; Brodie AM Prostate; 1995 Mar; 26(3):140-50. PubMed ID: 7534917 [TBL] [Abstract][Full Text] [Related]
7. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer. Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase. Li JS; Li Y; Son C; Brodie AM J Med Chem; 1996 Oct; 39(21):4335-9. PubMed ID: 8863811 [TBL] [Abstract][Full Text] [Related]
9. Effects of some novel inhibitors of C17,20-lyase and 5alpha-reductase in vitro and in vivo and their potential role in the treatment of prostate cancer. Nnane IP; Kato K; Liu Y; Lu Q; Wang X; Ling YZ; Brodie A Cancer Res; 1998 Sep; 58(17):3826-32. PubMed ID: 9731491 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds. Nnane IP; Kato K; Liu Y; Long BJ; Lu Q; Wang X; Ling YZ; Brodie A Endocrinology; 1999 Jun; 140(6):2891-7. PubMed ID: 10342882 [TBL] [Abstract][Full Text] [Related]
11. 4-pregnene-3-one-20 beta-carboxaldehyde: a potent inhibitor of 17 alpha-hydroxylase/C17,20-lyase and of 5 alpha-reductase. Li J; Li Y; Son C; Banks P; Brodie A J Steroid Biochem Mol Biol; 1992 May; 42(3-4):313-20. PubMed ID: 1606043 [TBL] [Abstract][Full Text] [Related]
12. Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo. Haidar S; Ehmer PB; Barassin S; Batzl-Hartmann C; Hartmann RW J Steroid Biochem Mol Biol; 2003 Apr; 84(5):555-62. PubMed ID: 12767280 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel oximes of 2-aryl-6-methoxy-3,4-dihydronaphthalene and their evaluation as inhibitors of 17 alpha-hydroxylase-C17,20-lyase (P450 17). Zhuang Y; Hartmann RW Arch Pharm (Weinheim); 1998 Jan; 331(1):36-40. PubMed ID: 9507700 [TBL] [Abstract][Full Text] [Related]
15. 3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer. Chan FC; Potter GA; Barrie SE; Haynes BP; Rowlands MG; Houghton J; Jarman M J Med Chem; 1996 Aug; 39(17):3319-23. PubMed ID: 8765515 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 21-trifluoropregnane steroids: inhibitors of 17 alpha-hydroxylase/17,20-lyase (17 alpha-lyase). Njar VC; Klus GT; Johnson HH; Brodie AM Steroids; 1997 Jun; 62(6):468-73. PubMed ID: 9185294 [TBL] [Abstract][Full Text] [Related]
17. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of Z- and E-1-methyl-2-(1-hydroximinoethyl)-6-methoxy-3,4-dihydronaphthalene and evaluation as inhibitors of 17 alpha-hydroxylase-C17,20-lyase (P450 17). Zhuang Y; Zapp J; Hartmann RW Arch Pharm (Weinheim); 1997 Nov; 330(11):359-61. PubMed ID: 9431028 [TBL] [Abstract][Full Text] [Related]